|
Session 113
Poster Abstracts
Childhood Vaccines
Wednesday, 1:30 - 3:30 pm
Poster Hall |
677
 |
Serologic Responses to Recall and Neoantigens in Severely Immunocompromised HIV-infected Children Initiating HAART
Mona Rigaud*1, W Borkowsky1, P Muressan2, A Weinberg3, P Larussa4, T Fenton2, J Read5, P Jean-Philippe6, E Ferguson7, B Zimmer8, and PACTG 1006 Team
1New York Univ Sch of Med, NY, US; 2Harvard Sch of Publ Hlth, Boston, MA, US; 3Univ of Colorado Hlth Sci Ctr, Denver, US; 4Columbia Univ Mailman Sch of Publ Hlth, New York, NY, US; 5PAMA, NICD, NIH, Bethesda, MD, US; 6DAIDS, NIAID, NIH, DHHS, Bethesda, MD, US; 7PAB, DAIDS, NIAID, Bethesda, MD, US; and 8Frontier Sci & Tech Res Fndn, Amherst, NY, US |
678
|
Phase I/II Randomized Trial of the Safety and Immunogenicity of Live Attenuated Influenza Vaccine vs Inactivated Influenza Vaccine in HIV+ Children; PACTG 1057
Sharon Nachman*1, M Levin2, L Song3, A Weinberg2, R Walker4, and Pediatric AIDS Clin Trials Group 1057
1Stony Brook Univ, NY, US; 2Univ of Colorado, Denver, US; 3Children's Hosp of Philadelphia, PA, US; and 4Medimmune, Gaithersburg, MD, US |
|
